
Loading, please wait...

Loading, please wait...

Clinicians widely recognize exclusive breastfeeding benefits, yet the underlying biological mechanisms remain a subject of intense research. Recent findings suggest that these benefits extend to the molecular level. A large-scale analysis has now identified specific epigenetic markers in children who were exclusively breastfed for at least three months. These markers represent chemical changes in DNA that influence gene expression without altering the genetic code itself.
Researchers from several institutions analyzed DNA methylation in blood samples from 3,421 children. Furthermore, they compared these samples with umbilical cord blood to establish a baseline. The results showed that breastfed children have distinct methylation patterns on genes associated with developmental and immune processes. Consequently, this study provides a potential link between early nutrition and long-term health outcomes.
The study specifically looked at DNA methylation, which often acts as a switch to silence certain genes. Notably, the methylation levels were higher in genes related to the immune system. Although the study did not measure direct health outcomes, it highlights how environmental factors like breastfeeding interact with our genes. Therefore, these findings support the recommendation for exclusive breastfeeding during the first months of life.
Moreover, the researchers identified six specific sites in the genome where these changes occur. The researchers directly linked three of these sites to a breastfeeding duration of more than three months. This suggests that the timing and duration of exclusive breastfeeding are critical factors. While we understand the cognitive advantages of breastfeeding, this epigenetic evidence adds a new layer to our understanding of child health.
Q1: What is the significance of DNA methylation in this study?
DNA methylation serves as a chemical 'off switch' for genes. In this context, it suggests that exclusive breastfeeding can silence or activate specific genes involved in immunity and growth, potentially shaping a child's health profile from an early age.
Q2: How many children were involved in this research?
The researchers analyzed data from 3,421 children across multiple countries, using samples collected through the Pregnancy and Childhood Epigenetics (PACE) Consortium. This large sample size enhances the reliability of the observed epigenetic patterns.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study reveals that exclusive breastfeeding for three months creates epigenetic marks on genes linked to immunity and developmental processes in childr...
6 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today